PAMU
ALXN

Pictet Asset Management (UK)’s Alexion Pharmaceuticals ALXN Stock Holding History

Pictet Asset Management (UK)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-76,300
Closed -$10.3M – 1058
2019
Q1 		$10.3M Buy
+76,300
New +$9.49M 0.02% 529

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Pictet Asset Management (UK)'s ALXN Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Alexion Pharmaceuticals (ALXN) stake by 37% in Q2 2021, selling an estimated $100M and leaving 982,218 shares worth $180M. The position accounts for 0.2% of the portfolio, ranked #144.

Pictet Asset Management (UK) first reported a position in ALXN in Q2 2013 and has held it in 33 quarters since. The position peaked at $304M in Q4 2020. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Pictet Asset Management (UK) held 982,218 shares of Alexion Pharmaceuticals worth $180M as of Q2 2021.
  • Pictet Asset Management (UK) sold 582,521 Alexion Pharmaceuticals shares in Q2 2021, an estimated $100M.
  • Alexion Pharmaceuticals made up 0.2% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #144 holding.
  • Pictet Asset Management (UK) first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
  • Pictet Asset Management (UK)'s Alexion Pharmaceuticals position peaked at $304M in Q4 2020.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.